BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 27297087)

  • 1. Neurovascular complications following carotid body paraganglioma resection.
    Lamblin E; Atallah I; Reyt E; Schmerber S; Magne JL; Righini CA
    Eur Ann Otorhinolaryngol Head Neck Dis; 2016 Nov; 133(5):319-324. PubMed ID: 27297087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Big Carotid Body Paraganglioma: A Case Report With Successful Surgical Excision and Literature Review.
    Lai YS; Tseng WL; Pan SC
    Ann Plast Surg; 2021 Feb; 86(2S Suppl 1):S119-S122. PubMed ID: 33438962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes and challenges of surgical extirpation for carotid body paraganglioma in South Korea: a single-center retrospective study.
    Shin J; Yun JS; Kim YW
    World J Surg Oncol; 2024 Apr; 22(1):112. PubMed ID: 38664798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors for postoperative cranial nerve complications in carotid body tumor resection: a retrospective cohort study.
    Alimohamad H; Yilmaz D; Marang-van de Mheen PJ; Jansen J; Hamming JF; Schepers A
    Int J Surg; 2023 Dec; 109(12):4057-4061. PubMed ID: 37720938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics analysis of carotid body tumor revealed potential mechanisms and molecular differences among Shamblin classifications.
    Lv Y; Gu G; Zeng R; Liu Z; Wu J; Zheng Y
    Exp Biol Med (Maywood); 2023 Oct; 248(20):1785-1798. PubMed ID: 37845830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carotid body tumor: retrospective analysis on 22 patients.
    Casarim AL; Tincani AJ; Del Negro A; Aguiar CG; Fanni RV; Martins AS
    Sao Paulo Med J; 2014; 132(3):133-9. PubMed ID: 24760216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study on the Influencing Factors of Short-Term Recovery of Neurological Symptoms after Carotid Body Tumor Resection.
    Yuan W; Huo R; Hou C; Wang Z; Yang J; Wang T
    World J Surg; 2023 Oct; 47(10):2542-2553. PubMed ID: 37280446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morbidity and Long-Term Patient-Reported Outcomes Following Advanced Carotid Body Tumor Resection.
    Gupta R; Dyba G; Malgor EA; Campana J; Nehler M; Malgor RD
    Ann Vasc Surg; 2023 May; 92():49-56. PubMed ID: 36736720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Risks to predict blood loss and cranial nerve injury in carotid body paraganglioma resection].
    Feng YH; Wu P; Tang YY; Liu Y; Wang XW; Qiu YZ; Zhang X
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 Dec; 58(12):1243-1247. PubMed ID: 38186100
    [No Abstract]   [Full Text] [Related]  

  • 10. Post-surgical complications of a Shamblin Type II carotid body tumor, a case study.
    Gowans C; Treat-Jacobson D
    J Vasc Nurs; 2023 Dec; 41(4):245-247. PubMed ID: 38072580
    [No Abstract]   [Full Text] [Related]  

  • 11. Non-Functional Carotid Body Tumors in Patients Without Somatic Mutations May Be Considered for Non-Operative Management.
    Reitz K; Ramos A; Speranza G; Chaer R; Singh M; Snyderman C; Hager E
    Ann Vasc Surg; 2022 Sep; 85():57-67. PubMed ID: 35472500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation on management of carotid body tumour (CBT). A twelve years experience.
    Boscarino G; Parente E; Minelli F; Ferrante A; Snider F
    G Chir; 2014; 35(1-2):47-51. PubMed ID: 24690341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microsurgery in carotid body paraganglioma.
    Mazzoni A; Franz L; Zanoletti E
    Acta Otorhinolaryngol Ital; 2024 Apr; 44(2):76-82. PubMed ID: 38651551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The carotid body and associated tumors: updated review with clinical/surgical significance.
    Butt N; Baek WK; Lachkar S; Iwanaga J; Mian A; Blaak C; Shah S; Griessenauer C; Tubbs RS; Loukas M
    Br J Neurosurg; 2019 Oct; 33(5):500-503. PubMed ID: 31130023
    [No Abstract]   [Full Text] [Related]  

  • 15. Novel insights into the classification of Shamblin III carotid body tumors from a neurosurgical perspective.
    Ma Q; Si Y; Sun M; Yuan W; Wu C; Han Y; Yin X; Yang J; Wang T
    Neurosurg Rev; 2024 Apr; 47(1):141. PubMed ID: 38578556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and treatment of carotid body paraganglioma: 21 years of experience at a clinical center of Serbia.
    Davidovic LB; Djukic VB; Vasic DM; Sindjelic RP; Duvnjak SN
    World J Surg Oncol; 2005 Feb; 3(1):10. PubMed ID: 15707500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of CT Angiography to Predict the Shamblin Group in Carotid Body Tumors.
    Shahbandari M; Arefinejad MS; Hajiahmadi S
    Indian J Otolaryngol Head Neck Surg; 2023 Sep; 75(3):1767-1773. PubMed ID: 37636716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR imaging-based risk stratification scoring system to predict clinical outcomes in carotid body tumors.
    Mahajan A; Shaikh A; Shukla S; Vaish R; Agarwal U; Smriti V; Rastogi S; Deokar S; Suryavanshi S; Chaturvedi P; Laskar SG; Prabhash K; Patil V; Noronha V; Menon N; Pai P; Pantvaidya G; Rane SU; Bal M; Mittal N; Patil A; Dcruz AK
    Front Oncol; 2023; 13():1200598. PubMed ID: 38348117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five-year outcome of a staged giant Shamblin type III carotid body tumor excision.
    Dittman JM; Ghodke BV; Moe KS; Singh N; Starnes BW
    J Vasc Surg Cases Innov Tech; 2023 Dec; 9(4):101320. PubMed ID: 37860726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical outcomes for carotid body tumour resection without preoperative embolization: a 10-year experience.
    Ridha B; Aram V; Baram A; Hama Baqi SY; Yaldo F
    Ann Med Surg (Lond); 2024 Apr; 86(4):2181-2188. PubMed ID: 38576983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.